The major dose-limiting and potentially life-threatening toxicity of Bleomycin, a key component of BEP chemotherapy for testicular cancer, is pulmonary fibrosis. Bleomycin causes direct damage to the lung tissue, leading to inflammation and scarring (fibrosis) of the alveoli. Symptoms can include dry cough, shortness of breath, and fever. The risk is dose-dependent and increases with higher cumulative doses, older age, and concurrent radiation therapy to the chest. Before each cycle of chemotherapy, patients undergo pulmonary function tests to monitor for early signs of lung damage. If significant toxicity develops, Bleomycin must be discontinued. Other side effects of Bleomycin include skin changes and mucositis, but pulmonary fibrosis is the most serious limitation to its use.

Break down complex topics into smaller, manageable chunks for easier recall.

Zambia

• loveness Phiri – 1084 pts

• Visual Pathway Lesions
• Positive and Negative Symptoms
• Hallucinations and Delusions
• Antipsychotic Medications
• Emergency: Environmental Emergencies